Alpha 2.0

» Articles » PMID: 29574623

Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update

Overview

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Specialty Cardiology & Vascular Diseases

Date 2018 Mar 26

PMID 29574623

Citations 3

Authors

Authors

Christopher Labos

George Thanassoulis

Affiliations

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: This review aims to summarize the research on genetic risk scores and their ability to improve risk prediction in both a primary and a secondary prevention population.

Recent Findings: Several groups have examined the role of genetic scores in different patient populations. Recent studies have capitalized on the growing number of identified genetic variants to construct polygenic risk scores that include hundreds and sometimes thousands of SNPs. Also, recent studies have demonstrated that individuals with high genetic risk scores can attenuate their risk with lifestyle modifications and with statins, for which the benefit of treatment may be greater in those at highest genetic risk. Genetic risk scores when added to existing clinical models appear to improve risk prediction, particularly in the setting of incident cardiovascular disease and may provide actionable information to optimize prevention early in life. Future research will need to establish how to best use this genetic risk information either as a means to further individualize treatment decisions or to better identify high-risk populations.

Citing Articles

Common genetic variants do not predict recurrent events in coronary heart disease patients.

Thompson P, Hui J, Beilby J, Palmer L, Watts G, West M BMC Cardiovasc Disord. 2022; 22(1):96.

PMID: 35264114 PMC: 8908687. DOI: 10.1186/s12872-022-02520-0.

Body mass index interacts with a genetic-risk score for depression increasing the risk of the disease in high-susceptibility individuals.

Anguita-Ruiz A, Zarza-Rebollo J, Perez-Gutierrez A, Molina E, Gutierrez B, Bellon J Transl Psychiatry. 2022; 12(1):30.

PMID: 35075110 PMC: 8786870. DOI: 10.1038/s41398-022-01783-7.

Interferon Regulatory Factor 5 () Gene Haplotypes Are Associated with Premature Coronary Artery Disease. Association of the Polymorphisms with Cardiometabolic Parameters. The Genetics of Atherosclerotic Disease (GEA) Mexican Study.

Posadas-Sanchez R, Cardoso-Saldana G, Fragoso J, Vargas-Alarcon G Biomolecules. 2021; 11(3).

PMID: 33802675 PMC: 8002496. DOI: 10.3390/biom11030443.

References

1.

Canto J, Kiefe C, Rogers W, Peterson E, Frederick P, French W . Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA. 2011; 306(19):2120-7. PMC: 4494683. DOI: 10.1001/jama.2011.1654. View

2.

Ardissino D, Berzuini C, Merlini P, Mannucci P, Surti A, Burtt N . Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction. J Am Coll Cardiol. 2011; 58(4):426-34. DOI: 10.1016/j.jacc.2010.11.075. View

3.

Tikkanen E, Havulinna A, Palotie A, Salomaa V, Ripatti S . Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease. Arterioscler Thromb Vasc Biol. 2013; 33(9):2261-6. PMC: 4210840. DOI: 10.1161/ATVBAHA.112.301120. View

4.

Sesso H, Lee I, Gaziano J, Rexrode K, Glynn R, Buring J . Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation. 2001; 104(4):393-8. DOI: 10.1161/hc2901.093115. View

5.

Hindieh W, Pilote L, Cheema A, Al-Lawati H, Labos C, Dufresne L . Association Between Family History, a Genetic Risk Score, and Severity of Coronary Artery Disease in Patients With Premature Acute Coronary Syndromes. Arterioscler Thromb Vasc Biol. 2016; 36(6):1286-92. DOI: 10.1161/ATVBAHA.115.306944. View

6.

Marenberg M, Risch N, Berkman L, Floderus B, de Faire U . Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994; 330(15):1041-6. DOI: 10.1056/NEJM199404143301503. View

7.

Abraham G, Havulinna A, Bhalala O, Byars S, De Livera A, Yetukuri L . Genomic prediction of coronary heart disease. Eur Heart J. 2016; 37(43):3267-3278. PMC: 5146693. DOI: 10.1093/eurheartj/ehw450. View

8.

Thanassoulis G, Pencina M, Sniderman A . The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines. JAMA Cardiol. 2017; 2(11):1175-1176. DOI: 10.1001/jamacardio.2017.2543. View

9.

Willer C, Sanna S, Jackson A, Scuteri A, Bonnycastle L, Clarke R . Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008; 40(2):161-9. PMC: 5206900. DOI: 10.1038/ng.76. View

10.

Krarup N, Borglykke A, Allin K, Sandholt C, Justesen J, Andersson E . A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals. Atherosclerosis. 2015; 240(2):305-10. DOI: 10.1016/j.atherosclerosis.2015.03.022. View

11.

Kullo I, Jouni H, Austin E, Brown S, Kruisselbrink T, Isseh I . Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial). Circulation. 2016; 133(12):1181-8. PMC: 4803581. DOI: 10.1161/CIRCULATIONAHA.115.020109. View

12.

Schunkert H, Konig I, Kathiresan S, Reilly M, Assimes T, Holm H . Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011; 43(4):333-8. PMC: 3119261. DOI: 10.1038/ng.784. View

13.

Bjornsson E, Gudbjartsson D, Helgadottir A, Gudnason T, Gudbjartsson T, Eyjolfsson K . Common sequence variants associated with coronary artery disease correlate with the extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2015; 35(6):1526-31. PMC: 5903266. DOI: 10.1161/ATVBAHA.114.304985. View

14.

Khot U, Khot M, Bajzer C, Sapp S, Ohman E, Brener S . Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003; 290(7):898-904. DOI: 10.1001/jama.290.7.898. View

15.

Mega J, Stitziel N, Smith J, Chasman D, Caulfield M, Devlin J . Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet. 2015; 385(9984):2264-2271. PMC: 4608367. DOI: 10.1016/S0140-6736(14)61730-X. View

16.

Hollands G, French D, Griffin S, Prevost A, Sutton S, King S . The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ. 2016; 352:i1102. PMC: 4793156. DOI: 10.1136/bmj.i1102. View

17.

Wauters E, Carruthers K, Buysschaert I, Dunbar D, Peuteman G, Belmans A . Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study. Eur Heart J. 2012; 34(13):993-1001. DOI: 10.1093/eurheartj/ehs389. View

18.

DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

19.

Mulders T, Meyer Z, van der Donk C, Kroon A, Ferreira I, Stehouwer C . Patients with premature cardiovascular disease and a positive family history for cardiovascular disease are prone to recurrent events. Int J Cardiol. 2010; 153(1):64-7. DOI: 10.1016/j.ijcard.2010.08.040. View

20.

Salfati E, Herrington D, Assimes T . Associations between a Genetic Risk Score for Clinical CAD and Early Stage Lesions in the Coronary Artery and the Aorta. PLoS One. 2016; 11(11):e0166994. PMC: 5115850. DOI: 10.1371/journal.pone.0166994. View